This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Profectus Biosciences, Inc.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Drago Robert Sliskovic: Innovator in Pharmaceutical Compounds
Introduction
Drago Robert Sliskovic is a notable inventor based in Chelsea, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various diseases. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Drago Robert Sliskovic holds 1 patent for his invention titled "Inhibitors of NF-κB." This invention relates to compounds of specific formulae and their pharmaceutically acceptable salts, which are intended for the treatment of cancer, inflammation, auto-immune diseases, diabetes and its complications, infections, cardiovascular diseases, and ischemia-reperfusion injuries.
Career Highlights
Drago is currently associated with Profectus Biosciences, Inc., where he continues to innovate and develop new therapeutic solutions. His work at Profectus has positioned him as a key player in the pharmaceutical industry, contributing to the advancement of treatments that address critical health issues.
Collaborations
Throughout his career, Drago has collaborated with esteemed colleagues, including Jie Zhang and Charles E. Ducker. These partnerships have fostered a collaborative environment that enhances research and development efforts in the pharmaceutical sector.
Conclusion
Drago Robert Sliskovic is a dedicated inventor whose work in pharmaceutical compounds has the potential to make a significant impact on healthcare. His innovative spirit and commitment to research continue to drive advancements in the treatment of various diseases.